1. Signaling Pathways
  2. TGF-beta/Smad
  3. TGF-β Receptor
  4. TGF-β Receptor Inhibitors

TGF-β Receptor Inhibitors

ALK1

ALK2

ALK3

ALK4

ALK5

ALK6

ALK7

TGFβR2

ACVR2A

ACVR2B

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

TGF-β Receptor Degraders & Inhibitors
Product Name ALK1 ALK2 ALK3 ALK4 ALK5 ALK6 ALK7 TGFβR2 ACVR2A ACVR2B Purity
SB-431542      
ALK4, IC50: 1 μM
ALK5, IC50: 0.75 μM
 
ALK7, IC50: 2 μM
      99.85%
Dorsomorphin  
ACVR1
BMPR1A
   
ALK6
        99.91%
A 83-01      
ALK4, IC50: 45 nM
ALK5, IC50: 12 nM
 
ALK7, IC50: 7.5 nM
      99.41%
Dorsomorphin dihydrochloride  
ACVR1
BMPR1A
   
ALK6
        99.91%
LDN193189  
ACVR1, IC50: 5 nM
BMPR1A, IC50: 30 nM
              99.48%
RepSox        
ALK5, IC50: 4 nM
          99.92%
Bimagrumab                
ACVR2A, Kd: 434 pM
ACVR2B, Kd: 1.7 pM
99.23%
LDN193189 Tetrahydrochloride  
ACVR1, IC50: 5 nM
BMPR1A, IC50: 30 nM
              99.86%
Vactosertib        
ALK5, IC50: 12.9 nM
          99.58%
A 83-01 sodium      
ALK4, IC50: 45 nM
ALK5, IC50: 12 nM
 
ALK7, IC50: 7.5 nM
      98.43%
LDN-212854
ALK1, IC50: 2.4 nM
ACVR1, IC50: 1.3 nM
BMPR1A, IC50: 85.8 nM
ALK4, IC50: 2133 nM
ALK5, IC50: 9276 nM
          99.70%
R-268712        
TGFBR1, IC50: 2.5 nM
          99.88%
ML347
ALK1, IC50: 46 nM
ACVR1, IC50: 32 nM
BMPR1A, IC50: 10800 nM
              99.94%
Sotatercept                
ACVR2A
  99.61%
SB-431542 (GMP)      
ALK4, IC50: 1 μM
ALK5, IC50: 0.75 μM
 
ALK7, IC50: 2 μM
     
Vactosertib Hydrochloride        
ALK5, IC50: 12.9 nM
          99.09%
OD36  
ACVR1, Kd: 37 nM
ACVR1, IC50: 47 nM
ALK2 R206H, IC50: 22 nM
                98.70%
IN-1130        
ALK5
          99.93%
EW-7195        
ALK5, IC50: 4.83 nM
          99.20%
AZ12799734
ALK1, Kd: 7.1 μM
ACVR1, Kd: 6.2 μM
BMPR1A, Kd: 40 μM
ALK4, Kd: 1 μM
ALK5, Kd: 0.74 μM
TGFBR1, IC50: 47 nM
ALK6, Kd: 0.017 μM
        98.07%
Itacnosertib  
ACVR1
   
ALK5
          99.06%
AZ12601011      
ALK4
   
ALK7
      99.88%
Zilurgisertib  
ALK2
                99.77%
ALK2-IN-2  
ACVR1, IC50: 9 nM
                99.56%
KER047 succinate  
ACVR1
                98.93%
KER047  
ACVR1
                99.35%
THRX-144644        
ALK5, IC50: 0.14 nM
          99.90%
ALK5-IN-34        
ALK5, IC50: <10 nM
          98.21%
TGFBR1-IN-1        
ALK5, IC50: 10-100 nM
         
ALK5-IN-33        
ALK5, IC50: ≤10 nM
         
M4K2308  
ALK2, IC50: 2 nM
   
ALK5, IC50: 224 nM
         
MU1700
ALK1, IC50: 13 nM
ALK2, IC50: 6 nM
     
ALK6, IC50: 41 nM
       
ALK5-IN-27        
ALK5, IC50: ≤10 nM
         
OD36 hydrochloride  
ACVR1, Kd: 37 nM
ACVR1, IC50: 47 nM
ALK2 R206H, IC50: 22 nM
               
J-1149        
ALK5, IC50: 0.017 μM
         
ALK5-IN-28        
ALK5, IC50: ≤10 nM
         
TGFβRII-IN-3              
TGF-βR2, IC50: 4.1 μM
   
M4K2281  
ALK2, IC50: 2 nM
   
ALK5, IC50: 350 nM
         
ALK5-IN-25        
ALK5, IC50: ≤10 nM
         
J-1063        
ALK5
         
TGFβRII-IN-2              
TGF-βR2, IC50: 2.4 μM
   
M4K2306  
ALK2, IC50: 7 nM
   
ALK5, IC50: 3915 nM